CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 185 filers reported holding CHINOOK THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 7.73 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $31,672,680 | +64.9% | 824,380 | -0.6% | 0.18% | +35.1% |
| Q1 2023 | $19,208,713 | -11.6% | 829,750 | 0.0% | 0.13% | +28.4% |
| Q4 2022 | $21,739,450 | +33.4% | 829,750 | +0.1% | 0.10% | +6.2% |
| Q3 2022 | $16,300,000 | +12.3% | 829,107 | -0.1% | 0.10% | -57.1% |
| Q2 2022 | $14,512,000 | +17.5% | 829,750 | +9.9% | 0.22% | +48.3% |
| Q1 2022 | $12,348,000 | +36.6% | 754,750 | +36.2% | 0.15% | +65.9% |
| Q4 2021 | $9,040,000 | – | 554,250 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 5,161,888 | $119,497,707 | 24.70% |
| Saturn V Capital Management LP | 506,818 | $11,732,837 | 8.76% |
| Octagon Capital Advisors LP | 2,551,703 | $59,071,924 | 8.50% |
| Affinity Asset Advisors, LLC | 976,021 | $22,594,886 | 7.46% |
| Frazier Life Sciences Management, L.P. | 4,345,559 | $100,599,691 | 7.28% |
| Altium Capital Management LP | 305,000 | $7,060,750 | 3.92% |
| Deep Track Capital, LP | 3,000,000 | $69,450,000 | 2.85% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 319,989 | $7,407,745 | 2.07% |
| Nan Fung Group Holdings Ltd | 113,950 | $2,637,943 | 1.80% |
| Nicholas Investment Partners, LP | 972,191 | $22,506,222 | 1.71% |